- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Register
- Orphan refused centr
- Molgramostim
Pharmaceuticals - Community Register
List of Orphan refusals for human medicinal products
Molgramostim
Product name: | Molgramostim |
Active substance: | Molgramostim |
Indication: | Treatment of cystic fibrosis |
Marketing Authorisation Holder: | Drugrecure Aps |
European Commission procedures |
Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
20/07/2010 | Refusal of orphan designation | EMEA/OD/082/09 | (2010)5064 of 16/07/2010 |